These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

107 related items for PubMed ID: 9137413

  • 1. Antitumor activity of new organometallic compounds in human ovarian cancer cell lines and comparison to platin derivatives.
    Moebus VJ, Stein R, Kieback DG, Runnebaum IB, Sass G, Kreienberg R.
    Anticancer Res; 1997; 17(2A):815-21. PubMed ID: 9137413
    [Abstract] [Full Text] [Related]

  • 2. cis-Amminedichloro(2-methylpyridine) platinum(II) (AMD473), a novel sterically hindered platinum complex: in vivo activity, toxicology, and pharmacokinetics in mice.
    Raynaud FI, Boxall FE, Goddard PM, Valenti M, Jones M, Murrer BA, Abrams M, Kelland LR.
    Clin Cancer Res; 1997 Nov; 3(11):2063-74. PubMed ID: 9815598
    [Abstract] [Full Text] [Related]

  • 3. An in vivo mouse reporter gene (human secreted alkaline phosphatase) model to monitor ovarian tumor growth and response to therapeutics.
    Nilsson EE, Westfall SD, McDonald C, Lison T, Sadler-Riggleman I, Skinner MK.
    Cancer Chemother Pharmacol; 2002 Feb; 49(2):93-100. PubMed ID: 11862422
    [Abstract] [Full Text] [Related]

  • 4. Antitumor activity of titanocene dichloride in xenografted human renal-cell carcinoma.
    Köpf-Maier P.
    Anticancer Res; 1999 Feb; 19(1A):493-504. PubMed ID: 10226588
    [Abstract] [Full Text] [Related]

  • 5. The Bcl-2/Bcl-XL family inhibitor ABT-737 sensitizes ovarian cancer cells to carboplatin.
    Witham J, Valenti MR, De-Haven-Brandon AK, Vidot S, Eccles SA, Kaye SB, Richardson A.
    Clin Cancer Res; 2007 Dec 01; 13(23):7191-8. PubMed ID: 18056200
    [Abstract] [Full Text] [Related]

  • 6. Comparative activity and distribution studies of five platinum analogues in nude mice bearing human ovarian carcinoma xenografts.
    Boven E, van der Vijgh WJ, Nauta MM, Schlüper HM, Pinedo HM.
    Cancer Res; 1985 Jan 01; 45(1):86-90. PubMed ID: 4038381
    [Abstract] [Full Text] [Related]

  • 7. Squalamine and cisplatin block angiogenesis and growth of human ovarian cancer cells with or without HER-2 gene overexpression.
    Li D, Williams JI, Pietras RJ.
    Oncogene; 2002 Apr 25; 21(18):2805-14. PubMed ID: 11973639
    [Abstract] [Full Text] [Related]

  • 8. Correlation of drug response with the ATP tumorchemosensitivity assay in primary FIGO stage III ovarian cancer.
    Konecny G, Crohns C, Pegram M, Felber M, Lude S, Kurbacher C, Cree IA, Hepp H, Untch M.
    Gynecol Oncol; 2000 May 25; 77(2):258-63. PubMed ID: 10785475
    [Abstract] [Full Text] [Related]

  • 9. Medical therapy of advanced malignant epithelial tumours of the ovary.
    Colombo N, Parma G, Bocciolone L, Franchi D, Sideri M, Maggioni A.
    Forum (Genova); 2000 May 25; 10(4):323-32. PubMed ID: 11535983
    [Abstract] [Full Text] [Related]

  • 10. Curcumin inhibits tumor growth and angiogenesis in ovarian carcinoma by targeting the nuclear factor-kappaB pathway.
    Lin YG, Kunnumakkara AB, Nair A, Merritt WM, Han LY, Armaiz-Pena GN, Kamat AA, Spannuth WA, Gershenson DM, Lutgendorf SK, Aggarwal BB, Sood AK.
    Clin Cancer Res; 2007 Jun 01; 13(11):3423-30. PubMed ID: 17545551
    [Abstract] [Full Text] [Related]

  • 11. Squalamine treatment of human tumors in nu/nu mice enhances platinum-based chemotherapies.
    Williams JI, Weitman S, Gonzalez CM, Jundt CH, Marty J, Stringer SD, Holroyd KJ, Mclane MP, Chen Q, Zasloff M, Von Hoff DD.
    Clin Cancer Res; 2001 Mar 01; 7(3):724-33. PubMed ID: 11297269
    [Abstract] [Full Text] [Related]

  • 12. Indoleamine 2,3-dioxygenase serves as a marker of poor prognosis in gene expression profiles of serous ovarian cancer cells.
    Okamoto A, Nikaido T, Ochiai K, Takakura S, Saito M, Aoki Y, Ishii N, Yanaihara N, Yamada K, Takikawa O, Kawaguchi R, Isonishi S, Tanaka T, Urashima M.
    Clin Cancer Res; 2005 Aug 15; 11(16):6030-9. PubMed ID: 16115948
    [Abstract] [Full Text] [Related]

  • 13. Potentiation of antitumor activities of carboplatin and camptothecin by interleukin-1 alpha against human ovarian carcinoma in vivo.
    Wang Z, Benchekroun MN, Sinha BK.
    Anticancer Res; 1994 Aug 15; 14(5A):1723-6. PubMed ID: 7847805
    [Abstract] [Full Text] [Related]

  • 14. Antitumor properties of some 2-[(dimethylamino)methyl]phenylgold(III) complexes.
    Buckley RG, Elsome AM, Fricker SP, Henderson GR, Theobald BR, Parish RV, Howe BP, Kelland LR.
    J Med Chem; 1996 Dec 20; 39(26):5208-14. PubMed ID: 8978849
    [Abstract] [Full Text] [Related]

  • 15. Development of a panel of 15 human ovarian cancer xenografts for drug screening and determination of the role of the glutathione detoxification system.
    Kolfschoten GM, Pinedo HM, Scheffer PG, Schlüper HM, Erkelens CA, Boven E.
    Gynecol Oncol; 2000 Mar 20; 76(3):362-8. PubMed ID: 10684711
    [Abstract] [Full Text] [Related]

  • 16. Antitumor activity of 13,14-dihydro-15-deoxy-delta7-prostaglandin-A1-methyl ester integrated into lipid microspheres against human ovarian carcinoma cells resistant to cisplatin in vivo.
    Sasaki H, Niimi S, Akiyama M, Tanaka T, Hazato A, Kurozumi S, Fukushima S, Fukushima M.
    Cancer Res; 1999 Aug 15; 59(16):3919-22. PubMed ID: 10463583
    [Abstract] [Full Text] [Related]

  • 17. Antitumor activity of cisplatin analogs against malignant ovarian tumor xenografts into nude mice.
    Hamaguchi K, Miyahara K, Nishimura H, Tashiro M, Kishi N, Matsumura T, Yakushiji M, Kato T.
    Nihon Sanka Fujinka Gakkai Zasshi; 1988 Nov 15; 40(11):1755-9. PubMed ID: 3069943
    [Abstract] [Full Text] [Related]

  • 18. Potentiation of platinum antitumor effects in human lung tumor xenografts by the angiogenesis inhibitor squalamine: effects on tumor neovascularization.
    Schiller JH, Bittner G.
    Clin Cancer Res; 1999 Dec 15; 5(12):4287-94. PubMed ID: 10632372
    [Abstract] [Full Text] [Related]

  • 19. Cisplatin inhibits paclitaxel-induced apoptosis in cisplatin-resistant ovarian cancer cell lines: possible explanation for failure of combination therapy.
    Judson PL, Watson JM, Gehrig PA, Fowler WC, Haskill JS.
    Cancer Res; 1999 May 15; 59(10):2425-32. PubMed ID: 10344753
    [Abstract] [Full Text] [Related]

  • 20. High effectiveness of platinum(IV) complex with adamantylamine in overcoming resistance to cisplatin and suppressing proliferation of ovarian cancer cells in vitro.
    Kozubík A, Horváth V, Svihálková-Sindlerová L, Soucek K, Hofmanová J, Sova P, Kroutil A, Zák F, Mistr A, Turánek J.
    Biochem Pharmacol; 2005 Feb 01; 69(3):373-83. PubMed ID: 15652229
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 6.